Novartis Oncology VP of Finance Salaries in Ithaca, NY | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology VP of Finance Salaries in Ithaca, NY

The average Novartis Oncology VP of Finance in Ithaca, NY earns an estimated $152,537 annually. Novartis Oncology's VP of Finance compensation is $53,993 less than the US average for a VP of Finance.

In Ithaca, NY, The Finance Department at Novartis Oncology earns $14,735 more on average than the Customer Support Department.

Last updated 3 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$152,537
Average Compensation
$152,537
avg. base

VP of Finance Salaries at Novartis Oncology

In Ithaca, NY, VPs of Finance earn $33,635 more than Accounting Managers.

Accounting Manager
$119k*
Senior Accountant
$90k*
Financial Analyst
$90k*
Business Analyst
$88k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Ithaca, NY, The Finance Department averages $14,735 more than the Customer Support Department, and $8,543 less than the Operations Department

Operations
$89,724 Avg. total comp.
+$9k
Finance
$81,181 Avg. total comp.
Customer Support
$66,446 Avg. total comp.
-$15k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Novartis Oncology reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Novartis Oncology reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at Novartis Oncology Rate Their Compensation

The majority of VPs of Finance at Novartis Oncology believe they're not compensated fairly. 100% of VPs of Finance at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company